Parag Mallick, founder and chief scientist of Nautilus Biotechnology, hopes his company’s solutions will unlock the secrets of proteins, the building blocks of biology. Being a magician as well, ...
New advancements in artificial intelligence have the capacity to deliver major breakthroughs in cancer therapy.
AI-powered protein design company Profluent used AI to make an open-source gene editor called OpenCRISPR-1.
OpenCRISPR-1 ...
Artificial intelligence is a rapidly improving technology. But its progress in drug development faces an increasingly urgent threat: An unending stream of overheated marketing.
To read of AI’s feats in ...
Late blight is an old foe of humans. This disease catalysed the devastating Irish potato famine that began in 1845.
It is caused by a fungus-like pathogen, which quickly kills ...
For stretched public health budgets, high-tech treatments are hard to afford but some pre-emptive measures can prove good value.
As hay fever season arrives, once again, for allergy and asthma ...
Much as ChatGPT generates poetry, a new A.I. system devises blueprints for microscopic mechanisms that can edit your DNA.
Generative A.I. technologies can write poetry and computer programs or create images of teddy ...
The most striking evidence that artificial intelligence can provide profound scientific breakthroughs came with the unveiling of a program called AlphaFold by Google DeepMind.
In 2016 researchers at the company ...
As OpenAI's CEO, Altman is widely considered to be the face of artificial intelligence, reprogramming the way we'll live and work for years to come. His relentless push into ...
Funding propels company’s proprietary platform consisting of Generative AI models and large-scale datasets purpose-built for designing and validating novel proteins, opening new frontiers in therapeutics and industrial applications
...
Expanding medical therapies based on Crispr gene-editing globally is “unrealistic” and the sector needs heavy investment to make the technology, which could transform treatment of diseases, accessible to all, ...
Venture capitalists are financing drugmakers seeking to improve upon today’s blockbuster weight-loss medications or combat their side effects.
New obesity medications have helped millions of people lose weight but can ...
Around 10 million. That’s the number of lives forecasters believe we will lose each year by 2050 as bacteria develop defenses against the drugs we use to fight infections.
Tackling antibiotic resistance, though, ...
BioAge Labs has reeled in the biotech industry’s largest private financing round so far in 2024 as the California startup goes full throttle on the hottest areas in obesity ...
Funding to advance Phase 2 clinical trials of azelaprag, an apelin receptor (APJ) agonist, in combination with Lilly’s Zepbound (tirzepatide) and therapeutic pipeline
Azelaprag improves metabolic and muscle ...
In his January 20, 2024 TEDxBerkeley Talk, Dr. Benjamin Oakes delves into the profound potential of CRISPR technology and its ability to transform healthcare.
Dr. Oakes is co-founder and ...
The Beacon for CRISPR Cures aims to create a roadmap for rapidly developing genome-editing therapies.
The story of CRISPR in medicine so far has been one of remarkable speed. It ...
Crispr recently marked a major milestone in medicine. But it's not time for a victory lap—the race is just beginning.
By Jennifer Doudna, CRISPR pioneer and Nobel Laureate at the ...
Joe Betts-LaCroix didn’t have time to wait for architects, construction workers or really any of the normal things that go into building a new office, let alone a new ...
Editing DNA with the same ease as spell-checking a Word document is a scientific holy grail. It would allow debilitating and deadly genetic diseases to not only be treated, ...
In a landmark decision, the Food and Drug Administration Friday approved the first gene-editing treatment to alleviate human illness.
The FDA approved two gene therapies for anyone 12 and older ...